Coverage 2 Control

Demand coverage that works for people with type 1 diabetes (T1D).


What is #Coverage2Control?

JDRF is calling on insurers, employers, drug companies and the government to provide these three things that will help people with type 1 diabetes (T1D) control the disease.


Lower out-of-pocket costs for insulin and supplies and make costs more predictable.


Give people the freedom to choose the treatment that’s right for them.


Cover all FDA-authorized technology and treatments for T1D.

Why better coverage matters

Right now, the ability to control T1D is at risk. It’s becoming harder and more expensive. Costs for insulin and diabetes management tools have soared and show no signs of stopping. To make matters worse, some insurers and employers have taken steps that limit patient choice and increase out-of-pocket costs. For the 1.45 million people with T1D, being able to choose and afford the tools they need to control their disease is critical to survival. Insurers, employers, drug companies and the government all have a responsibility to help.

Impact So Far

We’re making your voice heard where #Coverage2Control decisions are made – at insurance companies, employers, drug manufacturers, and at the U.S. Department of Health & Human Services.

Thousands of messages to insurers

50,000+ people signed the #Coverage2Control petition demanding better coverage for those living with T1D and 12 major groups signed on as partners. JDRF hand-delivered your petitions to the 25 largest health insurance companies, and supporters have sent thousands of personalized follow-up messages.

Artificial pancreas systems covered

All 25 of the nation’s largest health plans now cover artificial pancreas systems, including Anthem, which reversed its policy after hearing from JDRF and the T1D community.

Strongly Oppose Restrictions 

After UnitedHealthcare (UHC) announced it was extending its preferred insulin pump agreement to children as young as 7, we met with company leaders to urge them to reconsider this decision.  Following that meeting, tens of thousands of letters were sent to UHC by our community as part of this campaign urging this policy be changed. As a result, your voices were heard – on July 1, 2020 UHC revised their policy.

Progress toward lower insulin costs

JDRF has called on drug companies to lower list prices and do more to help the uninsured access affordable insulin. Assistance programs have expanded during the pandemic and JDRF has encouraged these expansions to be made permanent. JDRF continues to be deeply involved in ongoing conversations with Congress and the Administration about this important topic. Read our Congressional Testimony here.

Pressure from the #Coverage2Control campaign has prompted insurers to make improvements. Aetna and Blue Cross Blue Shield of North Carolina are passing drug discounts directly to their members. UnitedHealthcare expanded their drug discount program, announcing that in 2020 all new employer plans would have to pass drug discounts through to the people who need the drugs.



Become an Advocate

Spread the word

Materials and information to help you educate others.

Growing Support

Learn more about why JDRF is telling insurance companies to provide coverage that works for people with T1D.

See What’s at Stake

See why choice is so important for people with T1D, especially when it comes to choosing an insulin pump.

What JDRF is Fighting For

JDRF plays an important role in accelerating innovation and ensuring access for all Americans with T1D.

Our Partners

Thanks to our partners fighting for #Coverage2Control

Health Insurance Guide

Discover how to get the most #Coverage2Control from your health insurance with our free guide.